Literature DB >> 2896450

Parvaquone and buparvaquone: HPLC analysis and comparative pharmacokinetics in cattle.

L D Kinabo1, J A Bogan.   

Abstract

A high performance liquid chromatographic (HPLC) method for the determination of the antitheilerial drugs parvaquone and buparvaquone in plasma was developed. Both compounds were extracted from plasma with ether. After evaporating the extracts to dryness the residue was dissolved in methanol and an aliquot was injected onto a column (10 cm X 5 mm, i.d.) of ODS-Hypersil (5 mu) with a mobile phase of 0.05 M-Na acetate buffer (pH 3.6)-methanol (15:85, v/v). Detection was at 252 nm. The mean recovery for both compounds was about 92%. This method was used to elucidate their pharmacokinetics in 6 calves after intramuscular administration. The maximum plasma concentration for parvaquone was 6.36 +/- 0.58 micrograms/ml after 0.84 +/- 0.08 h. The corresponding values for buparvaquone were 0.102 +/- 0.030 microgram/ml and 3.17 +/- 0.39 h, respectively. The decay in plasma concentrations for the two drugs was biexponential and the terminal elimination half lives were 11.12 +/- 1.63 h and 26.44 +/- 2.81 h for parvaquone and buparvaquone, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896450

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  2 in total

1.  Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis.

Authors:  Joachim Müller; Adriana Aguado-Martínez; Luis-Miguel Ortega-Mora; Javier Moreno-Gonzalo; Ignacio Ferre; Matthew A Hulverson; Ryan Choi; Molly C McCloskey; Lynn K Barrett; Dustin J Maly; Kayode K Ojo; Wes Van Voorhis; Andrew Hemphill
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

Review 2.  Prevention of tick-borne diseases: challenge to recent medicine.

Authors:  Dominika Hromníková; Daniel Furka; Samuel Furka; Julio Ariel Dueñas Santana; Táňa Ravingerová; Vanda Klöcklerová; Dušan Žitňan
Journal:  Biologia (Bratisl)       Date:  2022-03-09       Impact factor: 1.653

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.